Quiescent Platelets Stimulate Angiogenesis and Diabetic Wound Repair

Journal of Surgical Research

Volumn 160, Issue 1, 2010, Pages 169-177

  Pietramaggiori, Giorgio ^a,b   Scherer, Saja S ^a   Mathews, Jasmine C ^a   Gennaoui, Tony ^c   Lancerotto, Luca ^b   Ragno, Gina ^c   Valeri, C Robert ^c   Orgill, Dennis P ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b UNIVERSITY OF PADOVA   (Italy)

^c Nav Blood Res Lab   (United States)

Author keywords

angiogenesis; diabetic wound repair; liquid preserved platelets; platelets frozen with and without DMSO

Indexed keywords

GLYCOPROTEIN IB; LIPOCORTIN 5;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EPITHELIZATION; FIBRIN CLOT; FIBRIN FORMATION; FLOW CYTOMETRY; GRANULATION TISSUE; HEMOSTASIS; HISTOLOGY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; WOUND CLOSURE; WOUND CONTRACTION; WOUND HEALING;

ANIMALS; BLOOD PLATELETS; CRYOPRESERVATION; CRYOPROTECTIVE AGENTS; DIABETES COMPLICATIONS; DIMETHYL SULFOXIDE; FLOW CYTOMETRY; HUMANS; MALE; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; PLATELET-RICH PLASMA; WOUND HEALING;

EID: 77950189016     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2008.09.010     Document Type: Article

References (30)

1. Complications of Diabetes in the United States. www.idf.org/home/index.cfm
2. Falanga V. Wound healing and its impairment in the diabetic foot. Lancet 366 (2005) 1736
3. Pietramaggiori G., Kaipainen A., Ho D., et al. Trehalose lyophilized platelets for wound healing. Wound Repair Regen 15 (2007) 213
4. Scherer S.S., Pietramaggiori G., Mathews J.C., et al. The mechanism of action of the vacuum assisted closure device. Plast Reconstr Surg 122 (2008) 786
5. Folkman J., Browder T., and Palmblad J. Angiogenesis research: Guidelines for translation to clinical application. Thromb Haemost 86 (2001) 23
6. Gnatenko D.V., Perrotta P.L., and Bahou W.F. Proteomic approaches to dissect platelet function: Half the story. Blood 108 (2006) 3983
7. Eppley B.L., Pietrzak W.S., and Blanton M. Platelet-rich plasma: A review of biology and applications in plastic surgery. Plast Reconstr Surg 118 (2006) 147e
8. Knighton D.R., Ciresi K.F., Fiegel V.D., et al. Classification and treatment of chronic nonhealing wounds. Successful treatment with autologous platelet-derived wound healing factors (PDWHF). Ann Surg 204 (1986) 322
9. Italiano Jr. J.E., Richardson J.L., Patel-Hett S., et al. Angiogenesis is regulated by a novel mechanism: Pro- and anti-angiogenic proteins are organized into separate platelet α-granules and differentially released. Blood 111 (2008) 1227
10. Ma L., Perini R., McKnight W., et al. Proteinase-activated receptors 1 and 4 counter-regulate endostatin and VEGF release from human platelets. Proc Natl Acad Sci U S A 102 (2005) 216
11. Bennett S.P., Griffiths G.D., Schor A.M., et al. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 90 (2003) 133
12. Frechette J.P., Martineau I., and Gagnon G. Platelet-rich plasmas: growth factor content and roles in wound healing. J Dent Res 84 (2005) 434
13. Singer A.J., and Clark R.A. Cutaneous wound healing. N Engl J Med 341 (1999) 738
14. Ma L., Hollenberg M.D., and Wallace J.L. Thrombin-induced platelet endostatin release is blocked by a proteinase activated receptor-4 (PAR4) antagonist. Br J Pharmacol 134 (2001) 701
15. Said H.K., Hijjawi J., Roy N., et al. Transdermal sustained-delivery oxygen improves epithelial healing in a rabbit ear wound model. Arch Surg 140 (2005) 998
16. Steed D.L. Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity ulcers. Plast Reconstr Surg 117 (2006) 143S discussion 150S
17. Steed D.L., Goslen J.B., Holloway G.A., et al. Randomized prospective double-blind trial in healing chronic diabetic foot ulcers. CT-102 activated platelet supernatant, topical versus placebo. Diabetes Care 15 (1992) 1598
18. Driver V.R., Hanft J., Fylling C.P., et al. Autologel Diabetic Foot Ulcer Study. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage 52 (2006) 68
19. Hoffmeister K.M., Josefsson E.C., Isaac N.A., et al. Glycosylation restores survival of chilled blood platelets. Science 301 (2003) 1531
20. Valeri C.R., Ragno G., and Khuri S. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at -80 degrees C without postthaw processing. Transfusion 45 (2005) 1890
21. Pietramaggiori G., Scherer S.S., Mathews J.C., et al. Healing modulation induced by freeze-dried platelet-rich plasma and micronized allogenic dermis in a diabetic wound model. Wound Repair Regen 16 (2008) 218
22. Barnard M.R., MacGregor H., Ragno G., et al. Fresh, liquid-preserved, and cryopreserved platelets: Adhesive surface receptors and membrane procoagulant activity. Transfusion 39 (1999) 880
23. Ni H., and Freedman J. Platelets in hemostasis and thrombosis: Role of integrins and their ligands. Transfus Apher Sci 28 (2003) 257
24. Valeri C.R., Ragno G., and Khuri S. In vitro effects of polymerized N-acetyl glucosamine (NAG) on the activation of platelets in platelet rich plasma with and without red blood cells. J Trauma 57 suppl (2004) S22
25. Xiao H.Y., Matsubayashi H., Bonderman D.P., et al. Generation of annexin V-positive platelets and shedding of microparticles with stimulus-dependent procoagulant activity during storage of platelets at 4 degrees C. Transfusion 40 (2000) 420
26. Becker G.A., Tuccelli M., Kunicki T., et al. Studies of platelet concentrates stored at 22 C and 4 C. Transfusion 13 (1973) 61
27. Slichter S.J., and Harker L.A. Preparation and storage of platelet concentrates. Transfusion 16 (1976) 8
28. Valeri C.R. Hemostatic effectiveness of liquid-preserved and previously frozen human platelets. N Engl J Med 290 (1974) 353
29. Wu J.R., Zhou C., Majumder R., et al. Role of procoagulant lipids in human prothrombin activation. 1. Prothrombin activation by factor X(a) in the absence of factor V(a) and in the absence and presence of membranes. Biochemistry 41 (2002) 935
30. Chan R.K., Liu P.H., Pietramaggiori G., et al. Effect of recombinant platelet-derived growth factor (Regranex) on wound closure in genetically diabetic mice. J Burn Care Res 27 (2006) 202